International Biotechnology Trust’s Kyntra Bio KYNB Stock Holding History

International Biotechnology Trust’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-788	Closed	-$201K	–	80
2021 Q3	$201K	Hold	788	–	–	0.05%	67
2021 Q2	$525K	Hold	788	–	–	0.14%	60
2021 Q1	$684K	Hold	788	–	–	0.18%	52
2020 Q4	$731K	Hold	788	–	–	0.2%	47
2020 Q3	$810K	Hold	788	–	–	0.26%	46
2020 Q2	$799K	Hold	788	–	–	0.27%	47
2020 Q1	$684K	Hold	788	–	–	0.31%	47
2019 Q4	$845K	Hold	788	–	–	0.3%	52
2019 Q3	$728K	Hold	788	–	–	0.34%	47
2019 Q2	$889K	Hold	788	–	–	0.33%	53
2019 Q1	$1.07M	Hold	788	–	–	0.4%	53
2018 Q4	$716K	Sell	788 -468	-37%	-$526K	0.44%	38
2018 Q3	$1.46M	Hold	1,256	–	–	0.7%	36
2018 Q2	$1.96M	Hold	1,256	–	–	0.75%	36
2018 Q1	$1.45M	Hold	1,256	–	–	0.57%	40
2017 Q4	$1.49M	Hold	1,256	–	–	0.52%	44
2017 Q3	$1.69M	Buy	+1,256	New	+$1.32M	0.66%	35

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

International Biotechnology Trust's KYNB Position: Q4 2021 in Review

International Biotechnology Trust sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 788 shares — an estimated $201K sold.

International Biotechnology Trust first reported a position in KYNB in Q3 2017 and held it in 17 quarters. The position peaked at $1.96M in Q2 2018. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

International Biotechnology Trust reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
International Biotechnology Trust sold 788 Kyntra Bio shares in Q4 2021, an estimated $201K.
International Biotechnology Trust first reported a position in Kyntra Bio in Q3 2017 and held it in 17 quarters.
International Biotechnology Trust's Kyntra Bio position peaked at $1.96M in Q2 2018.
162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on International Biotechnology Trust's 13F filing for Q4 2021, filed 15 Feb 2022.